SERVICES Having spent more than 30 years in the medical and pharmaceutical industry and more than 10 years in Asia, Dr. Tony Rebuck has gained knowledge of the industry’s players, processes, opportunities, and challenges. In addition to his professional positions, Dr. Rebuck has sat on many biopharma-related Advisory Boards. He has lectured at conferences around the globe and has presented to regulatory authorities, opinion leaders, and the media in many countries. Rebuck Consulting provides a second-opinion for all stages of decision making in drug development and provides due diligence for the investment community interested in Biopharmaceutical opportunities.   Our services includes:   Second Opinions Evaluating Clinical Research Programs: Phase I - IV - Offering a second opinion before submission to regulatory authorities Leveraging therapeutic area expertise in Diabetes, Oncology, Respiratory, and CNS Representing your views and plans as spokesman for media enquiries Presenting research plans and training opinion leaders Presenting a face for the company in new markets in Asia Writing abstracts and manuscripts for publication of new data Advising early-stage biopharmas on medical opportunities and risks of growth Due Diligence Serving on Advisory Boards Assessing Clinical Data and gap analysis Evaluating safety reports and clinical data to provide advice regarding safety and efficacy of drugs in development Reviewing technical data sheets or published articles